OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of $1.13 billion. The enterprise value is $1.23 billion.
| Market Cap | 1.13B |
| Enterprise Value | 1.23B |
Important Dates
The last earnings date was Monday, July 27, 2026, after market close.
| Earnings Date | Jul 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OPKO Health has 746.33 million shares outstanding. The number of shares has increased by 12.40% in one year.
| Current Share Class | 746.33M |
| Shares Outstanding | 746.33M |
| Shares Change (YoY) | +12.40% |
| Shares Change (QoQ) | -0.48% |
| Owned by Insiders (%) | 43.22% |
| Owned by Institutions (%) | 25.62% |
| Float | 323.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.90 |
| Forward PS | 1.97 |
| PB Ratio | 0.93 |
| P/TBV Ratio | 37.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.35, with a Debt / Equity ratio of 0.34.
| Current Ratio | 3.35 |
| Quick Ratio | 2.65 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.73 |
Financial Efficiency
Return on equity (ROE) is -5.88% and return on invested capital (ROIC) is -13.16%.
| Return on Equity (ROE) | -5.88% |
| Return on Assets (ROA) | -5.52% |
| Return on Invested Capital (ROIC) | -13.16% |
| Return on Capital Employed (ROCE) | -9.99% |
| Weighted Average Cost of Capital (WACC) | 11.51% |
| Revenue Per Employee | $258,416 |
| Profits Per Employee | -$32,040 |
| Employee Count | 2,275 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 7.39 |
Taxes
| Income Tax | -6.96M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.33% in the last 52 weeks. The beta is 1.49, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | +8.33% |
| 50-Day Moving Average | 1.39 |
| 200-Day Moving Average | 1.29 |
| Relative Strength Index (RSI) | 60.66 |
| Average Volume (20 Days) | 2,437,946 |
Short Selling Information
The latest short interest is 33.65 million, so 4.51% of the outstanding shares have been sold short.
| Short Interest | 33.65M |
| Short Previous Month | 32.88M |
| Short % of Shares Out | 4.51% |
| Short % of Float | 10.39% |
| Short Ratio (days to cover) | 7.62 |
Income Statement
In the last 12 months, OPKO Health had revenue of $587.90 million and -$72.89 million in losses. Loss per share was -$0.09.
| Revenue | 587.90M |
| Gross Profit | 114.48M |
| Operating Income | -167.89M |
| Pretax Income | -79.85M |
| Net Income | -72.89M |
| EBITDA | -78.17M |
| EBIT | -167.89M |
| Loss Per Share | -$0.09 |
Balance Sheet
The company has $300.76 million in cash and $398.08 million in debt, with a net cash position of -$97.32 million or -$0.13 per share.
| Cash & Cash Equivalents | 300.76M |
| Total Debt | 398.08M |
| Net Cash | -97.32M |
| Net Cash Per Share | -$0.13 |
| Equity (Book Value) | 1.18B |
| Book Value Per Share | 1.59 |
| Working Capital | 350.87M |
Cash Flow
In the last 12 months, operating cash flow was -$123.38 million and capital expenditures -$10.64 million, giving a free cash flow of -$134.02 million.
| Operating Cash Flow | -123.38M |
| Capital Expenditures | -10.64M |
| Depreciation & Amortization | 89.72M |
| Net Borrowing | -5.68M |
| Free Cash Flow | -134.02M |
| FCF Per Share | -$0.18 |
Margins
Gross margin is 19.47%, with operating and profit margins of -28.56% and -12.40%.
| Gross Margin | 19.47% |
| Operating Margin | -28.56% |
| Pretax Margin | -13.58% |
| Profit Margin | -12.40% |
| EBITDA Margin | -13.30% |
| EBIT Margin | -28.56% |
| FCF Margin | n/a |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.40% |
| Shareholder Yield | -12.40% |
| Earnings Yield | -6.53% |
| FCF Yield | -12.01% |
Analyst Forecast
The average price target for OPKO Health is $4.38, which is 188.16% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.38 |
| Price Target Difference | 188.16% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | -0.07% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.6 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.6 |
| Piotroski F-Score | 1 |